Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- FDGscan Also Provides Benefits to Existing PET Facilities
August 29, 2005
- R&D NEWS IN BRIEF
August 29, 2005
- AnGes MG, Avontec GmbH Sign Cross-licensing Agreement
August 29, 2005
- IMS Japan, ACNielsen Japan Launch OTC Market Analysis Tool
August 29, 2005
- Nippon Chemiphar Licenses NC-2300 to Velcura Therapeutics
August 29, 2005
- SELF-MEDICATION NEWS IN BRIEF
August 29, 2005
- Sales of Ethical Drugs Up 6% in April-June Period: IMS Japan
August 29, 2005
- JCQHC Analyzes 18 Surgical, 47 Drug-related Accidents
August 29, 2005
- Kainos to Strengthen Blood Transfusion Screening Business with Immucor
August 29, 2005
- Gov't-Managed Health Insurance Shows Surplus for 2nd Consecutive Year
August 29, 2005
- Toyobo Completes New Contract Production Facility in Otsu
August 29, 2005
- Spread of PET by FDG Delivery Service to Change Cancer Treatment Strategy
August 29, 2005
- BUSINESS NEWS IN BRIEF
August 29, 2005
- NEW PRODUCTS
August 29, 2005
- 1st Half Business Results
August 29, 2005
- 1st Qtr Business Results
August 29, 2005
- Caiapo Launched in Australia, New Zealand
August 29, 2005
- NHI Prices May Be Revised Once a Year if Generics Are Listed Twice a Year: Mr Mukaida
August 29, 2005
- Cabinet Approves \47.5 Tril. Ceiling for FY2006 Budget
August 29, 2005
- Measures Suggested for Drugs for Which Dissolution Tests Are Difficult: Quality Reevaluation
August 29, 2005
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…